Robert (Bob) Di Scipio, Esq. is a senior executive in the Life Science sector with extensive experience in manufacturing, software, data analytics and informatics, FDA & SEC regulatory compliance and new product commercialization.
He brings a wealth of knowledge in Enterprise Risk Management, corporate & tax law, and patent strategy and has served on audit and compensation committees. Bob has served in executive leadership and board of director roles in Life Science organizations, including Aegis Analytical Corporation (acquired by Dassault Systemes), which developed Discoverant, the leading manufacturing informatics software for the Life Science sector. [Abbot, Baxter, Biogen, Eli Lilly, Novartis, Pfizer and Astra Zeneca were among Aegis’ clients.] He has also served as the VP Business Development & Associate General Counsel of Martek Biosciences (NASDAQ:MATK, acquired by DSM), as the General Counsel & VP Corporate Development of OmegaTech (acquired by Martek), and as a tax attorney with PWC. A risk management and process improvement evangelist, Bob is passionate about mitigating FDA and SEC compliance risks and achieving excellence in manufacturing. As a result, he co-founded and currently serves as CEO & Chairman of Skyland Analytics Inc., a leading manufacturing, informatics and risk management consultancy which enables Life Science companies to meet their business goals and compliance obligations.
Learn More: www.skylandanalytics.net
Recent episodes from Mike Saunders, MBA (see all)
- Interview with Paul Seglund with Pacific Coast Wealth Builders - December 8, 2023
- Kim Magdalein w/Magdalein Financial -How Social Security Planners of America Helps Advisors Mitigate Taxes in Retirement for their clients - December 3, 2023
- Interview with Tim Tacl Co-Founder / Sr. Loan Officer at DNVR Lending - November 30, 2023